You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / CE

Alzheimer's Disease: Insights Into Optimal Care

  • Authors: Ronald C. Petersen, MD, PhD; James E. Galvin, MD, MPH; Gregory A. Jicha, MD, PhD
  • CME / CE Released: 10/11/2022
  • Valid for credit through: 10/11/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™

    Nurses - 0.75 ANCC Contact Hour(s) (0.25 contact hours are in the area of pharmacology)

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for neurologists, nurse practitioners (NPs), and nurses involved in the care of patients with Alzheimer's disease (AD).

The goal of this activity is that learners will be better able to diagnose early forms of AD and understand investigational therapies for AD management.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Clinically relevant tools to assess cognitive impairment in older adults 
    • Mechanism of action of emerging pharmacotherapies for the management of AD 
    • Clinical trial data for emerging pharmacotherapies for the management of AD
  • Have greater competence related to
    • Accurately diagnosing early stages of AD 


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


Session Chair

  • Ronald C. Petersen, MD, PhD

    Professor of Neurology
    Cora Kanow Professor of Alzheimer's Disease Research
    Director, Mayo Alzheimer's Disease Research Center
    Mayo Clinic College of Medicine
    Rochester, Minnesota

    Disclosures

    Ronald C. Petersen, MD, PhD, has the following relevant financial relationships:
    Consultant or advisor for: Biogen, Inc.; Eisai, Inc.; Genentech, Inc.; Nestle, Inc.; Merck, Inc.; Roche, Inc.

Faculty

  • James E. Galvin, MD, MPH

    Professor of Neurology
    Director of the Comprehensive Program for Brain Health
    University of Miami
    Miller School of Medicine
    Miami, Florida

    Disclosures

    James E. Galvin, MD, MPH, has the following relevant financial relationships:
    Consultant or advisor for: Alpha Cognition; Biogen; Cognivue; Eisai; PassageBio

  • Gregory A. Jicha, MD, PhD

    Professor of Neurology
    University of Kentucky
    College of Medicine
    Lexington, Kentucky

    Disclosures

    Gregory A. Jicha, MD, PhD, has the following relevant financial relationships:
    Contracted researcher for: AbbVie; Alector; Biohaven; Eisai; Lilly; Neurovision; Novo Nordisk

Editors

  • Meg Monday

    Senior Director, Content Development, Medscape, LLC 

    Disclosures

    Meg Monday has no relevant financial relationships. 

  • Frances McFarland, PhD, MA

    Associate Medical Education Director, Medscape, LLC  

    Disclosures

    Frances McFarland, PhD, MA, has no relevant financial relationships.   

Compliance Reviewer/Nurse Planner

  • Lisa Simani, APRN, MS, ACNP

    Associate Director, Accreditation and Compliance, Medscape, LLC 

    Disclosures

    Lisa Simani, APRN, MS, ACNP, has no relevant financial relationships. 

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Awarded 0.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

Alzheimer's Disease: Insights Into Optimal Care

Authors: Ronald C. Petersen, MD, PhD; James E. Galvin, MD, MPH; Gregory A. Jicha, MD, PhDFaculty and Disclosures

CME / CE Released: 10/11/2022

Valid for credit through: 10/11/2023

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

How Low Can We Go?: Striving for Early Diagnosis of Alzheimer's Disease

What is the earliest time that we can diagnosis Alzheimer's disease? What is the earliest time that we should diagnose Alzheimer's disease?
Gregory A. Jicha, MD, PhD

The Promise of Disease-Modifying Therapies in Alzheimer's Disease: What, When, and Who

What new therapies are in the pipeline, and how do they work?
James E. Galvin, MD, MPH